We are delighted to announce that the N+1 Singer Life Sciences and Healthcare Team has been ranked ‘Top Earnings Estimator’ in Biotechnology for the Europe region for 2018.
The awards are globally recognised as the gold standard in the objective measurement of sell-side research analysts. They measure performance based on the returns of their buy and sell recommendations relative to industry benchmarks; and the accuracy of earnings estimates. They are used by buy-side firms to identify the leading analysts at sell-side firms.
For more information on this news, please email email@example.com